國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacology and vitreoretinal surgery

Gandorfer, Arnd.

Pharmacology and vitreoretinal surgery

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacology and vitreoretinal surgeryvolume editor, Arnd Gandorfer.
其他作者:	Gandorfer, Arnd.
出版者:	Basel :S. Karger,2009
面頁冊數:	1 online resource :ill. (some col.)
附註:	A change of current concepts
標題:	RetinaSurgery.
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111
ISBN:	9783805590303

Pharmacology and vitreoretinal surgery
Pharmacology and vitreoretinal surgery[electronic resource] /volume editor, Arnd Gandorfer. - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Developments in ophthalmology,v. 441662-2790 ;. - Developments in ophthalmology ;v. 43..

A change of current concepts

Includes bibliographical references and indexes.

Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.

ISBN: 9783805590303Subjects--Topical Terms:

274929
Retina
--Surgery.

LC Class. No.: RE551 / .P43 2009

Dewey Class. No.: 617.7/3

National Library of Medicine Call No.: W1 / DE998NG v.44 2009

Pharmacology and vitreoretinal surgery
LDR:02105cmm a2200265 a 4500 001 310093
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cn|||||||||
008 111213s2009 sz ob 001 0 eng d
020 $a 9783805590303
035 $a 248111
040 $a szbaska
050 1 0 $a RE551 $b .P43 2009
060 0 0 $a W1 $b DE998NG v.44 2009
060 1 0 $a WW 250 $b P536 2009
082 0 0 $a 617.7/3 $2 22
245 0 0 $a Pharmacology and vitreoretinal surgery $h [electronic resource] / $c volume editor, Arnd Gandorfer.
260 $a Basel : $b S. Karger, $c 2009
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Developments in ophthalmology, $x 1662-2790 ; $v v. 44
500 $a A change of current concepts
504 $a Includes bibliographical references and indexes.
520 $a Since the advent of pars plana vitrectomy, immense technical advances in the treatment of retinal diseases have been made. However, some mechanically based limitations of vitreoretinal surgery may result in incomplete removal of the vitreous, especially at the vitreoretinal interface and at the vitreous base. Here, pharmacology can be of assistance. For instance, enzymes that cleave the vitreoretinal junction without damaging the retina or which induce liquefaction may be applied. Neuroprotective and antiproliferative agents may hold the promise of preserving neuronal function when the retina is detached or when proliferative vitreoretinopathy or proliferative diabetic retinopathy has developed. Earlier intervention is possible and can save visual function before the retinal cytoarchitecture is destroyed. Consequently, pharmacologic vitreolysis will change the current concepts of treating retinal and macular diseases.This volume is the first comprehensive up-date on pharmacology-assisted vitreoretinal surgery. Researchers in the fields of medical and surgical retina as well as retinal specialists and vitreoretinal surgeons in clinics will benefit from this topical summary.
650 0 $a Retina $x Surgery. $3 274929
650 0 $a Vitreous humor. $3 520727
650 0 $a Enzymes $x Therapeutic use. $3 219136
650 1 2 $a Vitreous Body $x surgery. $3 520728
650 2 2 $a Combined Modality Therapy. $3 520729
650 2 2 $a Retina $x surgery. $3 520730
650 2 2 $a Retinal Diseases $x surgery. $3 520731
650 2 2 $a Vitrectomy $x methods. $3 520732
650 2 2 $a Vitreous Body $x drug effects. $3 520733
700 1 $a Gandorfer, Arnd. $3 520726
830 0 $a Developments in ophthalmology ; $v v. 43. $3 520721
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=248111